These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2908234)

  • 21. [Calcium antagonists in the treatment of arterial hypertension].
    Chlewicka I; Wasowska T
    Pol Tyg Lek; 1982 Nov; 37(44):1327-9. PubMed ID: 6761674
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris].
    Verdecchia P
    Minerva Cardioangiol; 1993 Sep; 41(9):349-63. PubMed ID: 7903118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of nifedipine as third line therapy in the treatment of severe hypertension.
    Kendall MJ; Dean S
    Postgrad Med J; 1983; 59 Suppl 2():119-22. PubMed ID: 6136958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of nifedipine and verapamil on alpha-receptor-activation in patients with essential hypertension.
    Fritschka E; Distler A; Lenz T; Kribben A; Schudrowitsch L; Philipp T
    J Hypertens Suppl; 1984 Dec; 2(3):S535-8. PubMed ID: 6100753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Slow channel inhibitors verapamil and nifedipine in the management of hypertension.
    Gould BA; Hornung RS; Mann S; Balasubramanian V; Raftery EB
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S369-73. PubMed ID: 6184570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Depot nifedipine in the treatment of patients with essential and renal hypertension without renal insufficiency].
    Plaza de los Reyes M; Plaza de los Reyes X
    Rev Med Chil; 1985 May; 113(5):425-7. PubMed ID: 2869560
    [No Abstract]   [Full Text] [Related]  

  • 27. [Verapamil in combination therapy].
    Palócz E; Buday G; Kerkovits G
    Orv Hetil; 1985 Dec; 126(50):3089-93. PubMed ID: 2867512
    [No Abstract]   [Full Text] [Related]  

  • 28. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of calcium antagonists in the therapy of coronary heart disease].
    Meyer J
    Internist (Berl); 1983 Jul; 24(7):408-14. PubMed ID: 6136492
    [No Abstract]   [Full Text] [Related]  

  • 30. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
    Franz IW; Wiewel D
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1037-42. PubMed ID: 6085363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Verapamil and nitrendipine in beta blocker-resistant hypertensive patients].
    Edmonds D; Förster E; Wehling M; Siegenthaler W; Vetter W
    Schweiz Rundsch Med Prax; 1985 May; 74(19):510-3. PubMed ID: 3160098
    [No Abstract]   [Full Text] [Related]  

  • 32. Verapamil compared with nifedipine in the treatment of essential hypertension.
    Midtbø K; Hals O; van der Meer J
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S363-8. PubMed ID: 6184569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Stable angina pectoris: what is the role of calcium antagonists?].
    Tiberti G; Bossi M
    G Ital Cardiol; 1997 Oct; 27(10):1062-6. PubMed ID: 9410778
    [No Abstract]   [Full Text] [Related]  

  • 34. Hypotensive action of calcium antagonists as related to plasma noradrenaline and reactivity to noradrenaline.
    Schwietzer G; Distler A; Reeck S; Thiede HM; Philipp T
    J Hypertens Suppl; 1983 Dec; 1(2):102-4. PubMed ID: 6400109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Calcium antagonists in the treatment of arterial hypertension].
    Raczka A
    Pol Tyg Lek; 1983 Jan; 38(3):95-7. PubMed ID: 6866828
    [No Abstract]   [Full Text] [Related]  

  • 36. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Verapamil and beta-blockers in hypertension: a beneficial drug interaction?
    Dargie HJ
    Br J Clin Pract Suppl; 1985 Jun; 42():44-7. PubMed ID: 3929827
    [No Abstract]   [Full Text] [Related]  

  • 38. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV; Nedostup AV
    Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dynamic behavior of arterial pressure during exertion. Effects of treatment with 2 different calcium blockers: nifedipine and verapamil].
    González Juanatey JR; Pose Reino A; Amaro Cendón A; Gil de la Peña M
    Med Clin (Barc); 1988 Apr; 90(16):651-5. PubMed ID: 3294533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.